Seeking Alpha

Arena Pharmaceutical (ARNA): Q3 EPS loss of -$0.07 beats by $0.02. Revenue of $1.5M (-57% Y/Y)...

Arena Pharmaceutical (ARNA): Q3 EPS loss of -$0.07 beats by $0.02. Revenue of $1.5M (-57% Y/Y) misses by $2M. Shares +1.71% AH. (PR)
Comments (6)
  • Darrellt
    , contributor
    Comments (72) | Send Message
     
    Sort of immaterial numbers given that the future and Belviq is where we have to evaluate this stock.
    6 Nov 2012, 04:22 PM Reply Like
  • bil
    , contributor
    Comments (64) | Send Message
     
    looks like a buyout is long gone
    6 Nov 2012, 04:47 PM Reply Like
  • Veltri
    , contributor
    Comments (3) | Send Message
     
    How can they have revenue, they have not yet gone to market?
    6 Nov 2012, 04:54 PM Reply Like
  • Veltri
    , contributor
    Comments (3) | Send Message
     
    How can there be any revenue when their product has not yet been to market?
    6 Nov 2012, 04:54 PM Reply Like
  • Charles U. Farley
    , contributor
    Comments (14) | Send Message
     
    I am so glad you posted that.....[!]
    6 Nov 2012, 05:53 PM Reply Like
  • targa86guy
    , contributor
    Comments (3) | Send Message
     
    Revenue comes from mile stone payments.
    This stock is going to rise based on a well planned, and executed launch.
    6 Nov 2012, 11:53 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|